» Articles » PMID: 25949400

Specific Nutritional Problems in Acute Kidney Injury, Treated with Non-dialysis and Dialytic Modalities

Overview
Journal NDT Plus
Specialty Nephrology
Date 2015 May 8
PMID 25949400
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Patients who develop AKI, especially in the intensive care unit (ICU), are at risk of protein-energy malnutrition, which is a major negative prognostic factor in this clinical condition. Despite the lack of evidence from controlled trials of its effect on outcome, nutritional support by the enteral (preferentially) and/or parenteral route appears clinically indicated in most cases of ICU-acquired AKI, independently of the actual nutritional status of the patient, in order to prevent deterioration in the nutritional state with all its known complications. Extrapolating from data in other conditions, it seems intrinsically unlikely that starvation of a catabolic patient is more beneficial than appropriate nutritional support by an expert team with the skills to avoid the potential complications of the enteral and parenteral nutrition methodologies. By the same token, it is ethically impossible to conduct a trial in which the control group undergoes prolonged starvation. The primary goals of nutritional support in AKI, which represents a well-known inflammatory and pro-oxidative condition, are the same as those for other critically ill patients with normal renal function, i.e. to ensure the delivery of adequate nutrition, to prevent protein-energy wasting with its attendant metabolic complications, to promote wound healing and tissue repair, to support immune system function, to accelerate recovery and to reduce mortality. Patients with AKI on RRT should receive a basic intake of at least 1.5 g/kg/day of protein with an additional 0.2 g/kg/day to compensate for amino acid/protein loss during RRT, especially when daily treatments and/or high efficiecy modalities are used. Energy intake should consist of no more than 30 kcal non-protein calories or 1.3 × BEE (Basal Energy Expenditure) calculated by the Harris-Benedict equation, with ∼30-35% from lipid, as lipid emulsions. For nutritional support, the enteral route is preferred, although it often needs to be supplemented through the parenteral route in order to meet nutritional requirements.

Citing Articles

Impact of the prognostic nutritional index on renal replacement therapy-free survival and mortality in patients on continuous renal replacement therapy.

Lee Y, Lin P, Wu S, Hsu H, Yang S, Kor C Ren Fail. 2024; 46(2):2365394.

PMID: 38874108 PMC: 11232640. DOI: 10.1080/0886022X.2024.2365394.


The impact of higher protein dosing on outcomes in critically ill patients with acute kidney injury: a post hoc analysis of the EFFORT protein trial.

Stoppe C, Patel J, Zarbock A, Lee Z, Rice T, Mafrici B Crit Care. 2023; 27(1):399.

PMID: 37853490 PMC: 10585921. DOI: 10.1186/s13054-023-04663-8.


Critical illness myopathy and trajectory of recovery in acute kidney injury requiring continuous renal replacement therapy: a prospective observational trial protocol.

Teixeira J, Griffin B, Pal C, Gonzalez-Seguel F, Jenkins N, Jones B BMJ Open. 2023; 13(5):e072448.

PMID: 37217272 PMC: 10230984. DOI: 10.1136/bmjopen-2023-072448.


Acute kidney disease: an overview of the epidemiology, pathophysiology, and management.

Kung C, Chou Y Kidney Res Clin Pract. 2023; 42(6):686-699.

PMID: 37165615 PMC: 10698062. DOI: 10.23876/j.krcp.23.001.


5-Methyltetrahydrofolate Attenuates Oxidative Stress and Improves Kidney Function in Acute Kidney Injury through Activation of Nrf2 and Antioxidant Defense.

Wijerathne C, Au-Yeung K, Siow Y, O K Antioxidants (Basel). 2022; 11(6).

PMID: 35739943 PMC: 9219715. DOI: 10.3390/antiox11061046.


References
1.
Nielsen S, Grofte T, Gronbaek H, Tygstrup N, Vilstrup H . Opposite effects on regulation of urea synthesis by early and late uraemia in rats. Clin Nutr. 2007; 26(2):245-51. DOI: 10.1016/j.clnu.2006.11.005. View

2.
Marin A, Hardy G . Practical implications of nutritional support during continuous renal replacement therapy. Curr Opin Clin Nutr Metab Care. 2001; 4(3):219-25. DOI: 10.1097/00075197-200105000-00009. View

3.
Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M . Intensive insulin therapy in critically ill patients. N Engl J Med. 2002; 345(19):1359-67. DOI: 10.1056/NEJMoa011300. View

4.
Ando A, Kawata T, Hara Y, Yaegashi M, Arai J, Sugino N . Effects of dietary protein intake on renal function in humans. Kidney Int Suppl. 1989; 27:S64-7. View

5.
Franz M, Horl W . Protein catabolism in acute renal failure. Miner Electrolyte Metab. 1997; 23(3-6):189-93. View